NCT01374126View on ClinicalTrials.gov

Azithromycin Combination Therapy for the Treatment of Severe Malaria

PHASE2CompletedINTERVENTIONAL
Enrollment

75

Participants

Timeline

Start Date

July 31, 2011

Primary Completion Date

November 30, 2012

Study Completion Date

November 30, 2012

Conditions
Falciparum Malaria
Interventions
DRUG

Artesunate

Artesunate alone

DRUG

Azithromycin + Artesunate

Combination of azithromycin + artesunate

Trial Locations (1)

Unknown

MARIB, Bāndarban

All Listed Sponsors
collaborator

International Centre for Diarrhoeal Disease Research, Bangladesh

OTHER

lead

Medical University of Vienna

OTHER

NCT01374126 - Azithromycin Combination Therapy for the Treatment of Severe Malaria | Biotech Hunter | Biotech Hunter